VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 26, 2014

Primary Completion Date

December 5, 2017

Study Completion Date

December 18, 2020

Conditions
Chronic Venous DisorderVenous Outflow ObstructionSymptomatic Venous Outflow Obstruction of Iliofemoral Vein
Interventions
DEVICE

Veniti Vici™ Venous Stent System

Trial Locations (24)

10016

NYU School of Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

10065

New York Presbyterian Hospital/Cornell University, New York

23507

Sentara Vascular Specialists, Norfolk

27599

The University of North Carolina at Chapel Hill, Chapel Hill

48507

Michigan Vascular Center, Flint

52803

Midwest Cardiovascular Foundation, Davenport

70601

Imperial Health, LLP, Lake Charles

72211

Arkansas Site Management Services, LLC, Little Rock

79925

Dr. Ediberto Soto-Cora, El Paso

80112

Radiology Imaging Associates, Englewood

85016

Abrazo Arizona Heart Hospital, Phoenix

85254

Healthfinity PLCC, Scottsdale

92868

St. Joseph Hospital, Orange

98195

University of Washington Medical Center, Seattle

06820

Vascular Breakthroughs, Darien

Unknown

Infermerierie Protestante de Lyon, Décines-Charpieu

Hôpital Nord de Marseille, Marsaille

Klinikum Arnsberg, Karolinen Hospital, Arnsberg

University Hospital Galway, Galway

Rijnstate Ziekenhuis, Arnhem

University Hospital HM Monteprincipe, Madrid

Guy's and St Thomas' NHS Foundation Trust, London

University College London, London

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT02112877 - VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction | Biotech Hunter | Biotech Hunter